Rohto Pharmaceutical FY2027/3 Q1 Earnings Forecast Upward Revision

TOKYO, Aug 06 (Pulse News Wire) – ROHTO PHARMACEUTICAL CO.,LTD. (4527) has revised its FY2027/3 Q1 consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: millions of yen) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 369,500 43,800 46,100 34,500 Revised Forecast (B) 372,300 45,000 47,400 35,200 Change (B-A) 2,800 1,200 1,300 700 Change (%): Revenue +0.8% | OP +2.7% | OrdP +2.8% | NP +2.0% Prior Year Actual 343,725 41,118 47,971 34,247 KEY CHANGES: - Revenue forecast raised by +0.8% to 372,300 - Net profit forecast raised by +2.0% to 35,200 - Operating profit forecast raised by +2.7% to 45,000